Alberto Moreno

Endocrinología y Nutrición
Complejo Hospitalario Universitario de Jaén
#EndocrinologiaCHJaen

[Marta Araujo-Castro, MD, PhD @Marta_Araujo_C]

Nuestro artículo en Medicine‼️

📌Protocolo diagnóstico ante la sospecha de feocromocitoma

✍️Ante la sospecha de un feocromocitoma, el primer paso es demostrar que existe una producción excesiva de catecolaminas

https://t.co/lFBhPwCtbC

[Alberto Moreno @endoalb]

Definitiva https://t.co/fSSFYR1t5W

[Sharona Azriel @SharonaAzriel]

Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis | Diabetes Technology & Therapeutics https://t.co/FIwB75Q2uY

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

Download our new and improved Abridged Standards of Care (SOC), the go-to guide for primary care professionals, available for FREE. For the first time ever, we’ve condensed the SOC into easy to ready graphics. Don’t delay, download today! https://t.co/Lh8aXod9FR

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

A Swedish-based cohort study on familial aggregation and heritability of childhood-onset and adult-onset #T1D.

Findings suggest a larger contribution of environmental factors to the development of T1D in adults than in children.

Read it here: https://t.co/lJsjIbGaW0

[EstiUgarte @EstiUgarte]

Atypical Diabetes: What Have We Learned and What Does the Future Hold? https://t.co/pwDzytBePi

[Endocrine Connections @EndoConnect]

If you haven't already, read the @Soc_Endo guideline article on the diagnosis and management of post-bariatric hypoglycaemia. By @hazlehurst_j et al.

➡️➡️https://t.co/9ZRSGY2XT5

[Mercedes Codina @codinamar]

Mean Glucose and Gestational Weight Gain as Predictors of Large-for-Gestational-Age Infants in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitoring | Diabetes Technology & Therapeutics https://t.co/wy28xwxHas

[maría marques vidas @mmvidas]

@estebanjodar Muy importante: el inicio de iSGLT2 en FGe < 20 sigue protegiendo la progresión de la enfermedad renal y enlentece la llegada a diálisis!!

[SAEDYN @SAEDYN_]

👉👉👉HIPOGLUCEMIAS, ¿cómo actuar?
🔗vídeo en https://t.co/zHgbaLZovq

✏️En GUÍA DE SUPERVIVENCIA PARA LAS PERSONAS CON DIABETES Y SUS CUIDADORES multimedia @SAEDYN_

práctico, didáctico, sencillo

🔗Guía de supervivencia completa en https://t.co/CnHXFnhsCu

[Alberto Moreno @endoalb]

Saedyn 2024 equipazo

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Osteoporosis in men https://t.co/nEUY6qY5BK
#MensHealth #osteoporosis

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

#Glucagon, from past to present: a century of intensive research and controversies https://t.co/FfFclfQszb #diabetes #obesity
#FREE to read with registration (also FREE)

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

Diabetic kidney disease has high associated cardiovascular death. SGLT2 inhibitors or finerenone, when either is combined alone with RAS blockade, curtails DKD. Management of DKD requires a “pillared approach.” @ADA_Pubs

Read Here➡️https://t.co/MRFRYox7Gj

[European Society of Cardiology @escardio]

NEW: 2023 #ESCGuidelines for the management of #CardiovascularDisease in patients with #diabetes 👉
https://t.co/PCNsXMeMse

#ESCCongress #CVD

[Alfonso Valle @ValleAlfonso]

2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Principal new points 👇👇 @secardiologia @escardio #ESCCongress
⚠️Management HFpEF
⚠️Management HFmrEF

📥 https://t.co/ykRS4jhc8c

[Diabetologia @DiabetologiaJnl]

Incretins: turning the venom into the antidote. Read the Editorial on our 2023 Incretins in Metabolic Disease Special Issue! #Incretin #GLP1RA #T2D #T1D #MetabolicDisease https://t.co/7L7DI2bayh

[Cristina Tejera @cristinatejerap]

Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study @DiabetesCareADA

https://t.co/6DFKhPajLb

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement https://t.co/hrNXB9ycr0 #CGM #diabetes
#FREE to read with registration (also FREE)